Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

264.56 +3.55 (+1.36%)
Streaming Delayed Price Updated: 12:21 PM EDT, Oct 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Amgen

< Previous 1 2
...
22 23 24 25 26 27 28 29 Next >
Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics
Image Provided By Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
Via Benzinga
Can-Fite Expects Data Readout From Late-Stage Psoriasis Study With Piclidenoson In Q1 2022
Can-Fite BioPharma Ltd (NYSE: CANF) announced that the last of approximately 400 psoriasis patients enrolled in its Phase 3 Comfort study is scheduled to complete a 16-week... 
Via Benzinga
What 8 Analyst Ratings Have To Say About Amgen
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana... 
Via Benzinga
Time To Load Up? This Dividend Growth Stock Has Been Beat Down By 30%
Amgen is benefiting from a rising tide that is lifting all boats. Already, Amgen has increased its dividend for 11 consecutive years. 
Via Talk Markets
A Peek Into The Markets: US Stock Futures Mostly Higher; Crude Oil Up 2%
Pre-open movers U.S. stock futures traded mostly higher in early pre-market trade after the Nasdaq dropped close to 300 points in the previous session. Investors are awaiting... 
Via Benzinga
Exposures Fossil Fuels
Analyst Ratings For Amgen
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana... 
Via Benzinga
Where Amgen Stands With Analysts
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
Upgrades According to TD Securities, the prior rating for MAG Silver Corp (AMEX: 
Via Benzinga
5 Stocks To Watch For December 6, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Science Applications International Corporation (NYSE: SAIC) to report quarterly earnings at $1.50... 
Via Benzinga
4 Top Nasdaq-100 Stocks To Buy In December
The tech-heavy Nasdaq 100 trended higher this week amid the uncertainties surrounding inflation and the emergence of the Omicron coronavirus variant. So, we believe these fundamentally sound Nasdaq 100... 
Via Talk Markets
Exposures COVID-19
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy Incremental COVID-19 Vaccines From Moderna And Pfizer-... 
Via Benzinga
Exposures COVID-19
Janssen's Subcutaneous Darzalex Combo Wins FDA Approval For Pretreated Multiple Myeloma
Johnson & Johnson's (NYSE: JNJ) Janssen Biotech Inc has received FDA approval for Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with... 
Via Benzinga
Exposures Product Safety
Amgen's Otezla Meets Primary Goal In Late-Stage Genital Psoriasis Study
Amgen Inc (NASDAQ: AMGN) announced topline results from the DISCREET trial Phase 3 trial of Otezla (apremilast) in adults with moderate to severe genital psoriasis... 
Via Benzinga
7 Drug Stocks to Buy Now While They’re Still on Sale
Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead. 
Via InvestorPlace
Topics Supply Chain
Exposures COVID-19 Supply Chain
Amgen: For Growth And Income Investors
Amgen focuses on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. 
Via Talk Markets
Price Over Earnings Overview: Amgen
In the current market session, Amgen Inc. (NASDAQ:AMGN) is trading at $202.59, after a 0.75% gain. However, over the past month, the stock fell by 5.41%, and in the... 
Via Benzinga
Bristol Myers' Deucravacitinib Under FDA Review For Plaque Psoriasis
The FDA has accepted for review Bristol Myers Squibb & Co's (NYSE: BMY) deucravacitinib for the treatment of adults with moderate to severe plaque psoriasis... 
Via Benzinga
Exposures Product Safety
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
Affimed, Amgen, and Bristol Myers Squibb are too cheap to ignore right now. 
Via The Motley Fool
Exposures COVID-19
Should You Buy This Giant Biotech Stock?
Amgen beat analysts' earnings expectations in the third quarter, and its balance sheet remains admirable. 
Via The Motley Fool
10 Biggest Price Target Changes For Monday
MKM Partners cut Activision Blizzard, Inc. (NASDAQ:A... 
Via Benzinga
2 Dividend Stocks to Buy Right Now
These two drugmakers have a solid track record. 
Via The Motley Fool
3 Pharma Stocks That Could Make You Richer in November (and Beyond)
Two of them have already been big winners for investors this year. 
Via The Motley Fool
Here Are the Highlights From Amgen's Q3 Results
The big biotech reported only modest sales growth. 
Via The Motley Fool
3 Nasdaq Stocks to Buy and Hold for Years
Many companies are showing strong continued growth, but investors should focus on stocks to buy with the best long-term prospects. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Making a Difference When You Invest? Medexus Says It Improves Lives
Photo by Hernan Pauccara from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE: 
Via Benzinga
This Company Says Its New Topical Therapy Trials Bringing Hope to People Exposed to Biofilm Bacteria
Photo by Louis Reed on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner... 
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
How Are Biotech ETFs Reacting To These Q3 Earnings Releases?
There's no denying that the pandemic has opened up investment opportunities in the biotech sector by triggering a race to introduce vaccines. Let’s take a look at big biotech earnings releases to see... 
Via Talk Markets
< Previous 1 2
...
22 23 24 25 26 27 28 29 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.